
Millions of Britons taking gabapentin for chronic pain may face significantly heightened dementia risks, according to groundbreaking research that has prompted urgent calls for medication reviews among middle-aged patients.
A comprehensive study has revealed alarming associations between long-term gabapentin use and cognitive decline and found that patients receiving 12 or more prescriptions faced a 40% increased risk of developing dementia compared to those on lower doses.